SCL Science Inc. (KOSDAQ:246960)

South Korea · Delayed Price · Currency is KRW

2,195.00

+40.00 (1.86%)

At close: Apr 24, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			1.32B	369.78M	507.29M	596.19M	692.76M
Pharmaceuticals Growth			257.54%	-27.11%	-14.91%	-13.94%	35.25%
Total			1.32B	369.78M	507.29M	596.19M	692.76M
Total Growth			257.54%	-27.11%	-14.91%	-13.94%	35.25%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Korea			1.19B	208.94M	374.64M	529.65M	641.07M
Korea Growth			468.83%	-44.23%	-29.27%	-17.38%	40.11%
United States of America			104.02M	98.77M	119.63M	65.97M	47.90M
United States of America Growth			5.31%	-17.44%	81.33%	37.73%	-1.55%
Japan			1.62M	3.28M	10.29M	-	3.79M
Japan Growth			-50.70%	-68.07%	-	-	-20.02%
Greece			5.70M	9.73M	-	-	-
Greece Growth			-41.41%	-	-	-	-
Hong Kong			22.24M	14.05M	2.73M	569.00K	-
Hong Kong Growth			58.26%	414.65%	379.79%	-	-
Others			-	35.00M	-	-	-
Total			1.32B	369.78M	507.29M	596.19M	692.76M
Total Growth			257.54%	-27.11%	-14.91%	-13.94%	35.25%

Source: S&P Global Market Intelligence.